| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Glycopyrronium bromide |
| Brand | Seebri Breezhaler® |
| Indication | As a maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD). |
| Assessment Process | |
| Rapid review commissioned | 12/08/2012 |
| Rapid review completed | 17/08/2012 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended. |